chrisvoncsefalvay/vaers-outcomes huggingface dataset:
GOT THE SHOT AT 9:20AM. CALLED PHARMACY BACK AT AROUND 3:30PM REPORTING OF BASEBALL SIZE SWELLING AT THE INJECTION SITE. PT CONFIRMED NO DIFFICULTY BREATHING. I ADVISED PT TO USE COLD COMPRESS TO SEE IF THAT HELPS AND MONITOR THE SWELLING. PT CALLED BACK 30 MINUTES LATER REPORTING THE SWELLING IS GETTING WORST. I ADVISED PT TO SEEK MEDICAL ATTENTION BY CALL 911 OR GO TO THE EMERGENCY ROOM.
Sudden worsening of 4th cranial nerve palsy. Had surgery 2 years ago for it and had excellent correction but 2 days after vaccination started noticing recurrence of symptoms.  Coincidence versus reaction/side effect???
Initial report received on 17 October 2006 from a health care professional. A 34-year-old female patient had received an intramuscular injection of Fluzone SV 2006-2007, lot number U2239AA, on 17 October 2006. The patient had no illness at the time of vaccination. Within one hour following vaccination, the patient complained of difficulty breathing and chest tightness. Vital signs were "within normal limits." Oxygen saturation was 100%. The patient had no visible symptoms, no hives and no stridor. She was treated with Benadryl. The reporter indicated that the event did not require any emergency room or doctor visit. Recovery status was unknown. Follow-up information received on 05 March 2007 from a health care professional. It was unknown whether the patient had any diagnostic testing performed. The reporter noted "questionable anxiety."
COUGH, PNEUMONIA DX 5/2, LOSS OF APPETITE, DIARHHEA
PAIN BEGAN ON NOVEMBER 2ND, AND BY NOVEMBER 6TH, I NOTICED I COULD FEEL A LUMP.  I CONTACTED MY PCP AND WAS TREATED FOR CELLULITIS.  A FEW DAYS LATER I CALLED MY PCP BECAUSE THE ANTIBIODIC WASN'T HELPING.  AN MRI SHOWED THAT I HAD AN ABSCESS 3 INCHES LONG AND AN INCH THICK.  I SAW AN ORTHOPEDIC SURGEON ON NOV. 11TH, AND HAD SURGERY ON NOV. 12TH TO REMOVE THE ABSCESS.  I KNOW HAVE A 3-4 INCH INCISION HEALING ON MY LEFT SHOULDER.
Running temperature of 102.4 with beginning a rash on 9/27/00. Temperature decreased with Motrin and temperature elevated with activity. Seen by MD on 9/29/00 with temperature of 103 and dx'd with otitis. Rx'd antibiotics and macular rash on face, arms and legs. Mom states scabbed on 9/30/00 and temperature resolved by mom's report on 10/2/00.
Patient developed severe bloody nose 5 days after administration of vaccine. It did eventually stop on it's own. He also had moderate headache and cold sx starting 5 days after vaccination.
On March 15 (2 weeks after 1st Pfizer vaccine) I experienced sudden & extreme hearing loss in my left ear which has not gone away.  But I had no cold, flu or allergy that can explain this condition. I tried ear wax cleaner and oral decongestants but there has been on improvement on these 4 constant symptoms in the left ear. (1) sensation of blockage and medium hearing reduction  in voice range. (2) extreme low frequency hearing loss below 74 Hz  (10% of normal) (3) white noise "woosh" sound . (4) diplacusis (pitch shift) as follows:  tones heard 1/2 to 1 step UP between 200~800 hz / 1 to 2 steps DOWN between 1000~8000 hz. All symptoms are consistent with Cochlear Hydrops.
low back and abdominal pain, fever started the day following the vaccine. symptoms persisted for over 24 hour. took tylenol with minimal relief.
Information has been received from a consumer concerning her 16 year old son with no drug allergies and no medical history who on 30-JUL-2010 was vaccinated with the first dose of GARDASIL (lot # not reported). On 10-FEB-2011 the patient was vaccinated with the second dose of 0.5 ml GARDASIL (lot # not reported). Concomitant therapy included TYLENOL and MOTRIN. On 10-FEB-2010 while taking GARDASIL, the patient experienced headache, sore throat, ran a temperature and was dizzy. No treatment was given to the patient. Lab diagnostics studies were not performed. Vaccination with GARDASIL continued. At the time of reporting, the patient did not recover from the adverse events. The patient did not seek medical attention. Additional information has been requested.
patient experienced cataract surgery on 28Apr2021; This is a spontaneous report from a contactable consumer. A 86-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for Injection, Batch/Lot number: Unknown) via an unspecified route of administration on 18Mar2021 as single dose (at the age of 86-years-old) for COVID-19 immunization. Patients medical history included dementia, Patients concomitant medications included lidocaine. It was reported that the patient had cataract surgery on 28Apr2021 but that was the only procedure she has done lately. The patient received her first Pfizer covid vaccine on 18Mar2021 and was concerned that the recall might affect this somehow. The outcome of the event was unknown.  Information on batch/Lot number has been requested.  Follow-up (21Jul2021): This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
My period is 2.5 weeks late.  I?m not pregnant.  I?m not on birth control.  My periods are usually 28-32 days apart.  I have had uterine cramps for 2 weeks. No period.
Swelling on Rt arm redness & itching going below area of vaccine 2 days later swelling down & pt ok.
Patient was vaccinated at outside facility, subsequently admitted to our facility on 9/20/2021 due to symptomatic COVID and COVID test was positive on 9/21/2021
So, let's see and I am not positive about the first shot. A few weeks after the second shot instead of the soreness it seemed to come back. I would get a stabbing pain when I tried to put my hair up in a ponytail or put a shirt on. But the pain would get worse and worse. I was losing range of motion. It would also go across my back and into my shoulder blade. It was just kind of sore all over, it just took away my range of motion. I kept putting this off and did not care for myself, I put everything else first. I spoke to the nurse on call, and she recommended that I speak to my PCP and she recommended that I have the flu and shingles vaccine. Then I had the COVID-19 shot shortly thereafter. I thought I had them to close together. It just got worse and worse. When I would try to stretch, I would have this really intense pain in the same spot as the shot. On March 15, 2022 I saw my doctor in her office. She recommended an x-ray, and physical therapy. I just have not been able to do the x-ray yet and the doctor will not let me do PT until I have the x-ray. Nothing works the pain is not going away. I have been doing some stretches on my own, but I am still very limited with what I can do.
Information has been received from a nurse practitioner concerning a female with hypertension, hyperthyroidism, hyperlipidaemia, migraine and an allergy to ALEVE who was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine. On an unspecified date the patient experienced an allergy to 23v polysaccharide vaccine. At the time of the report the patient's status was unknown. A product quality complaint was not involved. The patient also had an adverse experience with zoster vaccine live (Oka/Merck) (MSD) (WAES # 0805USA02113). Additional information has been requested.
hot flashes; Night sweats; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: ER8736) via an unspecified route of administration in the arm left on 10May2021 at 15:15(at the age of 54-years-old)as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included estrogens conjugated, medroxyprogesterone acetate (PREMPRO), omeprazole magnesium (OMEPRAZOLE), multivitamins (Unspecified) and acetylsalicylic acid (BABY ASPIRIN) all for unknown indications and from unknown dates. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EW0161) via an unspecified route of administration in the arm left on 19Apr2021 at 15:15(at the age of 54-year-old) as a single dose for COVID-19 immunisation. The patient had no known allergies.  Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 11May2021, the patient experienced hot flashes and night sweats. The patient reported that she were previously managed the events by pempro and events were returned. Therapeutic measures were taken as a result of hot flashes and night sweats and included treatment with prempro ongoing at the time of report. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency department or urgent care. The clinical outcome of the events hot flashes and night sweats was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Patient presented <48 hours later with difficulty with speach. ED work up revealed hypertensive encephalopathy with expressive aphasia, SBP 197. No significant findings on MRI. also patient with headache and bilateral eye pain. Treated with nicardipine drip with near total resolution of his symptoms.
Child had fever after immunizations.  Parent consulted medical home, administered acetaminophen.  Highest temp 103.2 rectal.  Parent consulted Emergency Dept on next evening, as fever was still present.  Child's regular physician and ED physician agreed that fever was probable pertussis reaction, and decided that child should not receive DTP for future vaccine doses.
Woke up with fevers, chills, weakness, swollen lymph node in armpit - very painful. Required help to dress and undress, as it was too painful to move the left arm. On the following day, the area of the injection looked reddish and became tender. Throughout the day the fevers (39.1C) and chills continued, the read area became larger and more tender. On the next day the area was swollen, red and hot and measured around 3 inches.
Early period (2 weeks), intense exhaustion and body aches, heavy period mostly consisting of clots for 3+ days
Cellulitis. Went to doctor with large red swollen rash under skin, it was hot and hurt... Doctor prescribed antibiotic 4 times a day for 10 days...will return to doctor in 3 days.
Pain in multiple joints without synovitis, stiffness and pain in following joints: hands, wrists, shoulders, hips, knees.
Redness, swelling, hardness to shoulder area around injection site. Painful to the touch. Started when pt woke up this AM. Pt's mom advised to give Motrin, Benadryl and apply ice, continue to observe and recheck in our office in 2 days, or sooner if symptoms worsen.
Mouth went numb and throat tightened up within 5 min of injection. Was administered epipedrine and Benadryl  and taken to emergency room by ambulance and observed until noon and released.
Starting w/ 4th vax, had pain (as with previous 3) which gradually went away. At the beginning of Nov 1999, pain started grinding in the joint of shoulder were vax was administered.
I got shingles in Aug of 2021.  It was very mild. I went to urgent care about this.
pt said no redness or heat in area, but painful from day one until today.  Has been trying to resolve with ice/heat and Tylenol.  Called pharmacy today to report.  She stated painful in area and painful to lift arm and sleep on, not resolved much with above.  Gave vaers number and recommended continuing with current therapy or with suggestion from vaers.  I will call next week.
I did not have an adverse reaction to the vaccine. I received the vaccine on 09/13/2022 and tested positive via a home test for COVID-19 14 days later on 09/27/2022. I contacted my primary care doctor via the patient portal and was given the prescription on 09/27/2022. I retested and was negative on 10/04/2022 and 10/05/2022. I tested again today, 10/07/2022, and I was positive again. I have cold like symptoms with congestion, cough, chills and body aches.
After about 10 minutes of injection, developed itchiness and tightness of throat. Developed hives left side of face, under chin, neck and chest. Was also feeling dizzy during observation. Brought to our UCC, vitals stable (HR 80/BP 129/80/02 sat 99%)treated with solumedrol and Benadryl, discharged on prednisone, instructions for bendaryl and an EpiPen. On 1/14 evening, felt "vasovagal", took her vitals at home, per pt HR 39, BP 100/50 and throat felt "constricting". Went to ED, given epi, steroids, oxygen for comfort. No physical evidence of allergy however; ENT performed largynoscope, no mucosal edema or erythema, no rash. Discharged following day and has improved.
Information has been received from a physician via company employees and a practice manager referring to a patient of unknown age and gender. The patient's medical history, concurrent condition and concomitant therapy were not provided. On 24-MAR-2015 the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 0.5ml Prefilled Syringe (PFS) (lot # K020795, expiration date 19-MAR-2016, dose and route were unspecified). This specified lot number vaccine was exposed to temperature excursion once. The total cumulative excursion time was 16 hours with the lowest recorded temperature of 33 Fahrenheit degree. The storage criteria and the type of excursion for this vaccine was refrigerator (R). No adverse effects were reported. This is one of several reports received form the same source. Additional information has been requested.
pt recv vax 1FEB97 & 14FEB97 pt exp deterioration  & recurrent intractable focal unilateral sz;dx w/Rasmussen's encephalitis;condition progressively worsened;
Patient was administered an expired dose; This case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 11-year-old male patient who received Men ACWY-CRM NVS (Menveo) (batch number amaa19A, expiry date 21st October 2021) for prophylaxis.   On 30th November 2021, the patient received Menveo. On 30th November 2021, unknown after receiving Menveo, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.  Additional details were provided as follows: The age at vaccination was not reported. The patient was administered an expired dose of Menveo, which led to expired vaccine used. The reporter consented to follow up.
Information was received from a lawyer regarding a case in litigation involving a male patient, age and medical history not provided. On 09-JUN-2015 the patient was inoculated with ZOSTAVAX vaccine for routine adult health maintenance and the prevention of shingles at a clinic. The vaccine did not prevent shingles as intended and the patient subsequently contracted a persistent strain condition of herpes zoster. On or about 27-APR-2016, the patient was treated at a clinic for a blistering vesicular outbreak, which was diagnosed as herpes zoster or shingles. As a direct and proximate result of ZOSTAVAX or despite receiving ZOSTAVAX for prevention of shingles, the patient suffered painful injuries and damages and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, pain, suffering and other damages. Additional information has been requested.
Mom found baby unresponsive 12-23-2004. Went to hospital. 6/22/09 Autopsy report received DOS 12/24/04. Final Cause of Death: Probable encephalitis, Found face down in soft pillow.
Injection site my left shoulder hurt slightly/ Sore left injection site arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Injection site my left shoulder hurt slightly/ Sore left injection site arm) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029L20A and 037K20A) for COVID-19 vaccination.     No Medical History information was reported.   On 02-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Injection site my left shoulder hurt slightly/ Sore left injection site arm). At the time of the report, VACCINATION SITE PAIN (Injection site my left shoulder hurt slightly/ Sore left injection site arm) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant product was reported. No treatment medication was reported.
Pt developed pain, redness and swelling approx 2 inches posterior to vaccine injection site on left deltoid, within 24 hours of injection. Pt also had persistent bleeding from needle stick.
Patient was given HepA #1 and MMRV #1. Approx. 5 minutes later she developed a hive an her right thigh, closed to the MMRV injection site. She then developed a few more hives on her back. I called patient today to follow up-no rash after 8pm last night. No swelling or edema noted per parents-RN.
Patient came in for flu vaccine. Received Flubock instead of fluzone. Current age at vaccine was 16. No reactions
This spontaneous report was received from a medical assistant concerning an unspecified patient of unknown age and gender. The patient's concurrent conditions and medical history were not provided. On an unknown date from 02-APR-2018 to 15-MAY-2018, the patient was vaccinated with an improperly stored dose of Oka-Merck PROQUAD (Lot #: N021728, Exp Date:06-FEB-2019) (Lot#: N022972, Exp Date:19-FEB-2019), (Lot#: N029878, Exp Date: 22-APR-2019) or (Lot#: N025929, Exp Date: 18-MAR-2019) for prophylaxis, which had a temperature excursion of 6.1F for 5 minutes. Previous temperature excursion was 5.9 F for 45 minutes. The digital data logger was involved in recording the temperature excursion. The vaccine was reconstituted with properly stored dose of MERCK STERILE DILUENT (no more information was provided). No adverse effect was reported. No product quality complaint was involved. This is one of the several reports from the same source.  Sender's Comments: US-009507513-1805USA009899:Original Case : 1805USA006787 US-009507513-1805USA009900:Original Case : 1805USA006787 US-009507513-1805USA009901:Original Case : 1805USA006787 US-009507513-1805USA009902:Original Case : 1805USA006787 US-009507513-1805USA009903:Original Case : 1805USA006787 US-009507513-1805USA009904:Original Case : 1805USA006787 US-009507513-1805USA009905:Original Case : 1805USA006787 US-009507513-1805USA009906:Original Case : 1805USA006787 US-009507513-1805USA009907:Original Case : 1805USA006787 US-009507513-1805USA009908:Original Case : 1805USA006787 US-009507513-1805USA006787:Original Case : 1805USA006787 US-009507513-1805USA009910:Original Case : 1805USA006787 US-009507513-1805USA009911:Original Case : 1805USA006787 US-009507513-1805USA009912:Original Case : 1805USA006787 US-009507513-1805USA009913:Original Case : 1805USA006787 US-009507513-1805USA009914:Original Case : 1805USA006787 US-009507513-1805USA009915:Original Case : 1805USA006787 US-009507513-1805USA009916:Original Case : 1805USA006787 US-009507513-1805USA009917:Original Case : 1805USA006787 US-009507513-1805USA009918:Original Case : 1805USA006787 US-009507513-1805USA009919:Original Case : 1805USA006787 US-009507513-1805USA009920:Original Case : 1805USA006787 US-009507513-1805USA009921:Original Case : 1805USA006787 US-009507513-1805USA009922:Original Case : 1805USA006787 US-009507513-1805USA009923:Original Case : 1805USA006787 US-009507513-1805USA009924:Original Case : 1805USA006787 US-009507513-1805USA009925:Original Case : 1805USA006787 US-009507513-1805USA009926:Original Case : 1805USA006787 US-009507513-1805USA009927:Original Case : 1805USA006787 US-009507513-1805USA009928:Original Case : 1805USA006787 US-009507513-1805USA009929:Original Case : 1805USA006787 US-009507513-1805USA009930:Original Case : 1805USA006787 US-009507513-1805USA009931:Original Case : 1805USA006787 US-009507513-1805USA009932:Original Case : 1805USA006787 US-009507513-1805USA009933.
pt recv vax 22OCT96 or 23OCT96 pt devel vomiting & diarrhea w/o fever p/vax;pharmacist related there were other pt that exp vomit & diarrhea who did not recv vax;
shaking, chills & seizure are reported in pt who recvd fluogen on 30OCT92; reactions occurred @ 4AM on 2NOV92 & pt was adm to hosp on 3NOV; pt d/c fully recovered;
Pain in arm and numbness in fingers. Numbness continues up arm following activity. Pain occurs mostly with activity. Patient received a cortisone shot from office listed above but no relief (11/17/16).
a small slightly sore lump appeared on right side of lower neck, above collar bone; Swollen lymph nodes; This spontaneous case was reported by a patient and describes the occurrence of NECK MASS (a small slightly sore lump appeared on right side of lower neck, above collar bone) and LYMPHADENOPATHY (Swollen lymph nodes) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032L20A and 039K20A) for COVID-19 vaccination.     The patient's past medical history included Blood pressure high, Kidney stones, Osteopenia and High cholesterol. Concurrent medical conditions included Allergy to antibiotic (Bactrim) and Contrast media allergy (IVP dye). Concomitant products included AMLODIPINE, METOPROLOL SUCCINATE, CHLORTHALIDONE from 2018 to an unknown date, POTASSIUM CHLORIDE and ROSUVASTATIN for an unknown indication.   On 12-Jan-2021 at 7:30 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021 at 7:30 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-Feb-2021, the patient experienced NECK MASS (a small slightly sore lump appeared on right side of lower neck, above collar bone) and LYMPHADENOPATHY (Swollen lymph nodes). In February 2021, NECK MASS (a small slightly sore lump appeared on right side of lower neck, above collar bone) and LYMPHADENOPATHY (Swollen lymph nodes) had resolved.            It was reported that the patient called an endocrinologist who confirmed it was probably a swollen lymph node. Swelling disappeared within a couple of days.  No treatment medication was reported.   This case was linked to MOD-2021-021697, MOD-2021-023928 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 21-Apr-2021: Email address updated On 29-Apr-2021: Followreceived on 29-04-2021 and contains No NewInformation On 07-Jul-2021: Patient demographics were updated. The patient's medical history and allergies were added. Suspect dosing details were updated. Concomitant medication was added. Events start date was updated. Outcome of events was updated.
Right arm has spasms and pins and needles going up and down my right arm - very disturbing across my back, also.
Right upper arm swelling, edema and pain.  Event occurred within 24 hours of vaccination and resolving by 72 hours.  Treated symptomatically with ibuprofen.
1:42 PM C/O Left arm felt numb and feeling a little sleepy.  B/P 110/72 Benadryl 50 mg given po at 1:50 PM per verbal order of GONP.  2:00 C/O shortness of breath.  Pulse-60, Respirations-16.  Applied oxygen @ 2l/min.  2:05 C/O vein hurting in left arm and  mild pain in left wrist.  2:20 Reported only having pain in left wrist now and feeling some better B/P 110/72, P-60, R-16.  2:40 Oxygen d/c'ed.  2:45 PM B/P 112/78 P-60 R- 16 2:50 C/O itching around neck area.  No rash noted.  Oxygen Sat - 99% on room air.  3:00 Patient discharged to go home after reassessment by GONP.  Was instructed to get Benadryl and take one every 6 hours if needed for itching.  Also instructed to go to emergency room if shortness of breath or any new problems.  Patient and husband verbalized understanding of instructions per Spanish Interpreter.